Patents
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
05/2000
05/11/2000WO2000025791A1 Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
05/11/2000WO2000025788A1 Inhibitors of prenyl-protein transferase
05/11/2000WO2000025787A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000WO2000025786A1 Heterocyclic potassium channel inhibitors
05/11/2000WO2000025784A1 Method for improving the pharmacokinetics of tipranavir
05/11/2000WO2000025780A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme
05/11/2000WO2000025777A1 SUBSTITUTED PHENETHYLSULFONES AND METHOD OF REDUCING TNFαLEVELS
05/11/2000WO2000025776A1 Nitrosated and nitrosylated nonsteroidal antiinflammatory compounds, compositions and methods of use
05/11/2000WO2000025774A1 Benzamide potassium channel inhibitors
05/11/2000WO2000025770A1 Carbocyclic potassium channel inhibitors
05/11/2000WO2000025722A2 ENHANCED VACCINES COMPRISING SELF AND NON-SELF IgE PORTIONS OR DIMERIC ANTIGENS
05/11/2000WO2000025721A2 Sodium salt of 3-(4-cinnamyl-1-piperazinyl)imino-methyl rifamycin sv and process of preparation
05/11/2000WO2000009150A3 Cytokine and cytokine receptor, agonist, antagonist and/or antibody combination for therapeutic use
05/11/2000WO2000008158A3 Molecules designated ldcam
05/11/2000WO2000008043A3 Prevention and treatment of viral disease
05/11/2000WO2000008007A3 Cyclopentabenzofuran derivatives and their use
05/11/2000WO2000007618A3 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof
05/11/2000WO1999066956A9 IMMUNOLOGICAL AGENTS SPECIFIC FOR PRION PROTEIN (PrP)
05/11/2000DE19851282A1 Zusammensetzung einer pharmazeutisch wirksamen Substanz, appliziert in einem spezifischen Delivery-System zur Prävention und Behandlung von Infektions-Krankheiten Composition of a pharmaceutically active substance, applied in a specific delivery system for the prevention and treatment of infectious diseases
05/11/2000DE19850701A1 Benzoylpyridazine Benzoylpyridazine
05/11/2000CA2350052A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same
05/11/2000CA2349818A1 Membrane transport proteins
05/11/2000CA2349567A1 Pyrazolopyridine derivatives as selective cox-2 inhibitors
05/11/2000CA2349505A1 Nucleic acid constructs for genetic immunization
05/11/2000CA2349504A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/11/2000CA2349331A1 Multicomponent meningococcal vaccine
05/11/2000CA2349232A1 Benzoylpyridazines
05/11/2000CA2348960A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/11/2000CA2348958A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/11/2000CA2348777A1 Rotavirus subunit vaccine
05/11/2000CA2348756A1 Enhanced vaccines
05/11/2000CA2348728A1 Method for the production of quercetin and isoquercetin derivatives
05/11/2000CA2348703A1 Inhibitors of prenyl-protein transferase
05/11/2000CA2348446A1 Benzamide potassium channel inhibitors
05/11/2000CA2348421A1 Protein
05/11/2000CA2348392A1 Method for producing luteolin and luteolin derivatives
05/11/2000CA2348267A1 Novel inhibitors of impdh enzyme
05/11/2000CA2348234A1 Compounds derived from an amine nucleus that are inhibitors of impdh enzyme
05/11/2000CA2348063A1 Method for preparing solid phase conjugate vaccines
05/11/2000CA2347650A1 Transmembrane 4 proteins
05/11/2000CA2347188A1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2347119A1 Inhibition of differentiation of cytotoxic t-cells by p-selectin ligand (psgl) antagonists
05/11/2000CA2347060A1 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
05/11/2000CA2346131A1 Method for improving the pharmacokinetics of tipranavir
05/11/2000CA2312430A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity
05/10/2000EP0999212A1 Furopyridine antibacterials
05/10/2000EP0998585A1 SCREENING METHODS USING AN ATPASE PROTEIN FROM A VIRUS OF THE $i(FLAVIVIRIDAE) FAMILY
05/10/2000EP0998576A2 Bovine adenovirus type 3 genome
05/10/2000EP0998568A1 Mutant having uracil phosphoribosyl transferase activity
05/10/2000EP0998493A1 Epitopes of shigella like toxin and their use as vaccine and in diagnosis
05/10/2000EP0998480A1 Nucleotide analog composition and synthesis method
05/10/2000EP0998295A1 The process for the preparation of a stable fixed dose pharmaceutical composition of anti infective agent/agents and micro organisms as active ingredients
05/10/2000EP0998293A1 Cytokine related treatments of disease
05/10/2000EP0925065A4 Water miscible erythromycin solutions
05/10/2000EP0818202A4 Dna-rna hydrid and a dna preparation, methods of obtaining said hybrid and preparation from sturgeon milt, and a pharmaceutical compound based on said dna-rna hybrid
05/10/2000CN1252808A Antipathogenic synthetic piptides and compositions comprising them
05/10/2000CN1252790A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252730A Lyme combination compositions and uses
05/10/2000CN1252719A Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment
05/10/2000CN1252713A N-hydroxy-2-(alkyl, aryl or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
05/10/2000CN1252307A AIDS vaccine injecta
05/10/2000CN1252306A Pumonary tuberculosis treating medicine liquid and its preparation
05/10/2000CN1252299A Antiphlogistic cough-relieving medicine
05/10/2000CN1252285A Preparation of AIDS resisting medicine from indian stringbush root extract
05/10/2000CN1052240C Method for preparing inhibitor of retroinfection viral protease
05/10/2000CN1052233C Alkaloids from mappia foetida, the use and formulations containing them
05/10/2000CA2287775A1 Attenuated forms of bovine viral diarrhea virus
05/09/2000US6060604 Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
05/09/2000US6060600 Substituted tetronic acids useful for treating HIV and other retroviruses
05/09/2000US6060597 Cyclic oligosaccharide, and an agent containing the same for preventing or treating retroviral diseases
05/09/2000US6060595 Inhibition of viral replication
05/09/2000US6060494 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
05/09/2000US6060484 Anti-viral method
05/09/2000US6060479 Quinazoline-4-one AMPA antagonists
05/09/2000US6060476 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
05/09/2000US6060308 RNA respiratory syncytial virus vaccines
05/09/2000US6060294 Alanyl tRNA synthetase from Staphylococcus aureus
05/09/2000US6060280 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins
05/09/2000US6060259 Having molecular weight in presence of sodium dodecyl sulfate of between 44.5 and 47.5 kilodaltons; for detecting or monitoring the development of tuberculosis in man or cattle
05/09/2000US6060239 Cellubrevin homologs
05/09/2000US6060085 Dissolved drug that has the capacity to permeate the stratum corneum layer of the epidermis and become available systemically, and a drug in a microparticulate state that does not readily cross the stratum corneum
05/09/2000US6060067 Process for the preparation of tetanus toxoid vaccine
05/09/2000US6060065 Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission
05/09/2000US6060059 Haemophilus adhesion proteins
05/09/2000US6060058 Vaccine for conferring bacterial immunity containing lactoferrin receptor protein
05/09/2000CA2112239C Enantiomeric hydroxylated xanthine compounds
05/09/2000CA2100586C Htlv-i and htlv-ii peptide antigens and methods
05/09/2000CA2011532C Formulation
05/04/2000WO2000024922A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids
05/04/2000WO2000024911A2 Human phospholipases
05/04/2000WO2000024907A2 Library of novel "unnatural" natural products
05/04/2000WO2000024902A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024896A2 Biological material for preparing pharmaceutical compositions for treating mammals
05/04/2000WO2000024886A1 Prv-1 gene and the use thereof
05/04/2000WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents
05/04/2000WO2000024779A1 Lysine-rich statherin protein
05/04/2000WO2000024773A2 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
05/04/2000WO2000024765A2 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024763A1 Single morphic forms of known peptide metalloproteinase inhibitors
05/04/2000WO2000024730A1 Organic vanadium(iii) complexes and their use